鄭巧蘭
簡介

專業(yè):流行病與衛(wèi)生統(tǒng)計學(xué)

?

發(fā)表文章情況:

[1] 鄭巧蘭,林燕薇,洪悅民,楊江瑜.科技期刊編輯如何利用統(tǒng)計知識篩查學(xué)術(shù)不端行為.編輯學(xué)報,2021,33(01):74-77.

[2] 洪悅民,楊江瑜,林燕薇,鄭巧蘭. 醫(yī)藥衛(wèi)生期刊借力“一網(wǎng)兩微”推進(jìn)科研誠信建設(shè)初探.中國科技期刊研究,2021,32(10):1287-1293.

[3] Fang T, Chen M, Yu W, Ma T, Su Z, Chan DYL, Zhao M, Zheng Q, Wang W. The predictive value of endometrial thickness in 3117 fresh IVF/ICSI cycles for ectopic pregnancy. J Gynecol Obstet Hum Reprod,2021,50(8):102072.

[4] Gu Y, Lian Y, Zheng Q, Huang Z, Gu L, Bi Y, Li J, Huang Y, Wu Y, Chen L, Huang Y. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B. BMC Infect Dis, 2020,20(1):509.

[5]張雪芳,智生芳,黃云,鄭巧蘭,張純,黃曉紅,梁栩維.轉(zhuǎn)移灶~(18)F-FDG PET/CT代謝參數(shù)對初診轉(zhuǎn)移鼻咽癌患者預(yù)后預(yù)測價值.腫瘤影像學(xué),2020,29(04):357-364.

[6]張雪芳,智生芳,鄭巧蘭,吳國謙,梁栩維,尹岫茅,張純.~(18)F-FDG PET/CT中不同部位SUVmax對預(yù)測初治轉(zhuǎn)移鼻咽癌預(yù)后的價值.中國醫(yī)學(xué)影像學(xué)雜志,2019,27(10):745-748+753.

[7] Wei FF, Zheng QL, Li MY, Wu MS. The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore):2017,96(19):e6835.

[8] Zheng QL, Tian Q, Hao C, et al. Comparison of attitudes toward disability and people with disability among caregivers, the public, and people with disability: findings from a cross-sectional survey. BMC Public Health, 2016,16(1):1024.

?

聯(lián)系電話:020-85253470